.png)
.png)
Director
University of Arizona, Valley Fever Center for Excellence
Disclosure(s): No financial relationships to disclose
John Natale Galgiani was born in San Francisco, California, residing there until receiving a Bachelor of Arts Degree in Biology from Stanford University. He then attended Medical School at Northwestern Medical School. After Internship at Virginia Mason Hospital in Seattle, Washington, Dr. Galgiani’s second year of residency was completed at the Santa Clara Valley Medical Center in San Jose, California. He was a Fellow in Infectious Diseases at Stanford University for two and a half years and completed his training with an appointment as Chief Resident in Internal Medicine at Pacific Medical Center, San Francisco, California. In 1978, Dr. Galgiani moved to Tucson, joining the faculty of the University of Arizona College of Medicine where he is currently a tenured Professor.
Dr. Galgiani has focused his career on Arizona’s special problems with coccidioidomycosis (Valley fever). His work has included estimating the impact of Valley fever on the general population and on special groups such as organ transplant recipients and patients with AIDS. For 19 years, as part of the NIH-sponsored Mycoses Study Group, Dr. Galgiani was the project director of a coccidioidomycosis clinical trials group. He was a Principal Investigator in the Valley Fever Vaccine Project. More recently, he is leading a UA group to develop a UAriona-invented vaccine for dogs and humans.
In 1996, Dr. Galgiani established the University of Arizona Valley Fever Center for Excellence to disseminate information about Valley fever, help patients with the severest complications of this disease, and to encourage research into the biology and diseases of its etiologic agent. In 2021, this effort was expanded within ABOR’s New Economy Initiative to coordinate the collaboration of all three Arizona public universities.